Given the influence of various factors such as the distinct classifications of FISH and IHC in differentiating prognosis, clinical and pathological characteristics, and tumor heterogeneity in outcomes, we recognize the potential of detecting the gene status of HER2 as being more effective than evaluating its protein status. Here, ERBB2 is linked to neoplasm.